DJO's parent company completed its orthopedic spinoff, Enovis, on schedule April 4.
ESAB will begin trading on the N.Y. stock exchange April 5, according to a news release. About 54 million shares of ESAB common stock were distributed to Enovis shareholders.
The spinoff was announced in November, along with a new name for the orthopedic business, from Colfax to Enovis. In 2019, Colfax acquired devicemaker DJO.